Harmony Biosciences Holdings, Inc. ( HRMY) - Key Metrics
HRMY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $4.51 | $1.30 | $1.60 | $1.60 |
| 2026Q1 | $3.73 | $0.56 | $0.48 | $0.48 |
| 2025Q4 | $4.23 | $0.39 | $2.19 | $2.19 |
| 2025Q3 | $4.10 | $0.87 | $1.86 | $1.86 |
| 2025Q2 | $3.49 | $0.69 | $1.38 | $1.38 |
HRMY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 7.00 |
| 2026Q1 | 0% | 12.50 |
| 2025Q4 | 0% | 23.99 |
| 2025Q3 | 0% | 7.83 |
| 2025Q2 | 0% | 11.45 |
HRMY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 4.39% | 0% |
| 2026Q1 | 1.71% | 0% |
| 2025Q4 | 5.84% | 0% |
| 2025Q3 | 6.74% | 0% |
| 2025Q2 | 4.37% | 0% |
HRMY
Price: $38.12
52 week price:
Payout Ratio Range:
Earnings Per Share: 3.14 USD
P/E Ratio: 12.42
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 87588
Market Capitalization: 2.3 billion